Navigation Links
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
Date:10/2/2013

WOONSOCKET, R.I., Oct. 2, 2013 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.  MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma.

Under the terms of the new research agreement, Dr. Ghanekar will also evaluate a targeted nanoparticle version of MCT-485 for the treatment of liver cancer.  The targeted nanoparticle version of MCT-485 is being developed in collaboration with Genisphere LLC, a DNA nanotechnology company.  MultiCell is investigating the use of Genisphere's DNA nanoparticle drug delivery technology to enable the targeted delivery of MCT-485 to the tumor and away from normal tissues.

Hepatocellular carcinoma is the most common form of primary liver cancer, and is a leading cause of cancer death worldwide with over 1 million cases reported annually.  Hepatocellular carcinoma remains an unmet medical need, and today's approaches for treatment are of limited efficacy.   MCT-485, possessing both oncolytic and immune activating properties, could be superior to doxorubicin, cisplatin and other currently marketed therapies by providing a more robust activation of immunity, and a more global and longer lasting anti-tumor effect.

About MCT-485

MultiCell Technologies' MCT-485 is a noncoding double stranded micro RNA (miRNA), and the first of a family of prospective cancer therapeutics based on the use of our patented TLR3 signaling technology.  MultiCell owns rights to several issued U.S. and foreign patents
'/>"/>

SOURCE MultiCell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
2. Modality Solutions Releases New White Paper on Thermal Shipping Technologies
3. NPI Volunteers Carry ‘Essential Technologies’ Message to Congress
4. Hurel Corporation Announces Grant Program Based On Its 3-D Tissue Construct Technologies, Readies Call For Research Proposals From Academic Community
5. Smart Imaging Technologies Enables Digital Pathology Workflow with Interactive Web Reports
6. Global Forensic Technologies And Services Industry
7. Emergent Technologies Selected to Serve 50 of the World’s Most Innovative Companies
8. TriCore Reference Laboratories Named First Next-Generation Sequencing Center of Excellence by Life Technologies
9. Life Technologies Tops Life Sciences Sector of Dow Jones 2013 Sustainability Index
10. AEgis Technologies Announces Official Launch of ADME WorkBench Software for Pharmacokinetics Prediction
11. Discovery Channel MythBuster Star Jaime Vendera First Person on Record to Break a Glass with His Voice Endorses UV-Aid by UV Technologies, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MN (PRWEB) May 28, 2015 ... it a point to ask his audiences if ... future trends including robotics, solar cells, fuel cells, ... 3D printers, advanced battery storage technology, driverless cars, ... and high-quality but inexpensive online education. , ...
(Date:5/28/2015)... MA (PRWEB) May 28, 2015 ... located in Basel, Switzerland, and the Alliance ... a Cambridge, Massachusetts-based non-profit organization operating in ... a global system to enhance quality, safety, ... development and health research, are pleased to ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
(Date:5/27/2015)... Israel , May 27, 2015  Tikcro Technologies ... quarter ended March 31, 2015. ... quarter, we continued pre-clinical work to generate functional specific ... an early stage, we are encouraged by the development ... field as new antibodies which modulate immune checkpoints gain ...
Breaking Biology Technology:Futurist Jack Uldrich to Deliver 4 Keynote Addresses in June 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
... on terror includes fighting the dark side of deadly ... Raushel is helping with the fight by developing an ... organophosphates. , Synthetic organophosphates started their journey as insecticides ... the dangerous alleys of chemical warfare during World War ...
... team are researching nano-scale cantilevers that have the potential to ... the air. Put them into a small handheld device and ... in industry, in health care and even at home. , ... work has been something we,ve only seen so far in ...
... Although naturally occurring smallpox was eradicated in 1977, ... a laboratory and release it into the population. Under ... insufficient for universal administration. In a study published in ... of Medicine , researchers found that lifetime protection is ...
Cached Biology Technology:Researcher working on destruction of chemical weapons 2Clemson researchers advance nanoscale electromechanical sensors 2New study indicates smallpox vaccination effective for decades 2
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. ... that its wholly owned subsidiary, 3D-ID LLC, a company ... Team Battelle for the biometrics technology portion of the ... Contract from the Department of the Army. ... products developed for government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... Cincinnati (UC) have identified key molecular components linking circadian ... , providing insights that could lead to improved disease ... the UC College of Medicine Department of Molecular and ... findings Monday, Jan. 13, online ahead of print in ...
... of Illinois study has identified the three most significant risk ... a parental BMI that classifies the mom or dad as ... eating in order to control his weight. "We looked ... of child obesity, and the three that emerged as strong ...
... concentrations of serum long-chain omega-3 fatty acids may help reduce ... of Eastern Finland study published recently in Diabetes Care ... fish oils. Type 2 diabetes is becoming increasingly widespread ... risk factor, which means that diet and other lifestyle factors ...
Cached Biology News:Researchers identify key components linking circadian rhythms and cell division cycles 2Illinois study identifies 3 risk factors most highly correlated with child obesity 2Fish derived serum omega-3 fatty acids help reduce the risk of type 2 diabetes 2
Sheep polyclonal to Trenbolone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule: 17 alpha Trenbolone(3)-BTG....
... chain (human), clone 41D GenBank ... : Native clusterin purified from human ... 0.15M NaCl and 0.05% sodium azide ... lysates from HeLa cells or MCF-7 ...
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Chlamydia pneumoniae (TWAR)...
Biology Products: